Javascript must be enabled to continue!
Endobronchial Involvement in Sarcoidosis
View through CrossRef
Endobronchial involvement is a common feature of sarcoidosis. The mucosa may appear normal or there may be inflammatory changes with erythematous lesions, miliary nodules, and, rarely, mass-like lesions leading to obstruction. In patients with bronchial lesions, the bronchial biopsy may be positive in three-quarters of patients. On the other hand, granulomas may be identified in one-third of patients with a normal mucosa. Current data on endobronchial sarcoidosis is primarily associated with the treatment and prognosis of obstructive mass-like granulomas. Data relevant to clinical features of superficial endobronchial involvement and its implications on prognosis and extrapulmonary organ involvement is lacking. The results of our two previous studies reveal that clinical findings of endobronchial disease may be different. These studies also suggest that there is a great difference between patients with no endobronchial involvement, limited and diffuse endobronchial disease in regard to clinical features, and prognosis. The incidence of extrapulmonary organ involvement is also significantly different between the three groups. In this short review, the clinical findings of endobronchial sarcoidosis have been defined, the effects of superficial endobronchial involvement on prognosis, and extrapulmonary organ involvement.
Title: Endobronchial Involvement in Sarcoidosis
Description:
Endobronchial involvement is a common feature of sarcoidosis.
The mucosa may appear normal or there may be inflammatory changes with erythematous lesions, miliary nodules, and, rarely, mass-like lesions leading to obstruction.
In patients with bronchial lesions, the bronchial biopsy may be positive in three-quarters of patients.
On the other hand, granulomas may be identified in one-third of patients with a normal mucosa.
Current data on endobronchial sarcoidosis is primarily associated with the treatment and prognosis of obstructive mass-like granulomas.
Data relevant to clinical features of superficial endobronchial involvement and its implications on prognosis and extrapulmonary organ involvement is lacking.
The results of our two previous studies reveal that clinical findings of endobronchial disease may be different.
These studies also suggest that there is a great difference between patients with no endobronchial involvement, limited and diffuse endobronchial disease in regard to clinical features, and prognosis.
The incidence of extrapulmonary organ involvement is also significantly different between the three groups.
In this short review, the clinical findings of endobronchial sarcoidosis have been defined, the effects of superficial endobronchial involvement on prognosis, and extrapulmonary organ involvement.
Related Results
Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review
Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review
Background: Endobronchial squamous cell carcinoma is one of the most common types of tumors located inside the tracheobronchial tree. Patients often present in advanced stages of t...
Fluoroscopic guidance of Arndt endobronchial blocker placement for single‐lung ventilation in small children
Fluoroscopic guidance of Arndt endobronchial blocker placement for single‐lung ventilation in small children
Background: Thoracoscopic surgery may require single‐lung ventilation (SLV) in infants and small children. A variety of balloon‐tipped endobronchial blockers exist but the placeme...
Sarcoidosis
Sarcoidosis
Sarcoidosis is a systemic disease characterized by the presence of noncaseating granulomas, which accumulate in affected organs. The incidence, organ involvement, and disease sever...
Sarcoidosis
Sarcoidosis
Sarcoidosis is a systemic disease characterized by the presence of noncaseating granulomas, which accumulate in affected organs. The incidence, organ involvement, and disease sever...
Antimycobacterial immune responses in patients with pulmonary sarcoidosis
Antimycobacterial immune responses in patients with pulmonary sarcoidosis
AbstractIntroduction: Sarcoidosis is a multisystem granulomatous disease of unknown origin. Pathogenetic involvement of Mycobacterium tuberculosis has frequently been discussed in...
Genetic association of lipids and lipid-lowering drug target genes with sarcoidosis
Genetic association of lipids and lipid-lowering drug target genes with sarcoidosis
Abstract
Objective:
Todetermine the potential causal association between serum lipid levels and sarcoidosis, and to investigate the potential impact of lipid-lowering agent...
Drug‐induced sarcoidosis: an overview of the WHO pharmacovigilance database
Drug‐induced sarcoidosis: an overview of the WHO pharmacovigilance database
AbstractBackgroundThere is a documented association between drug exposure and sarcoidosis‐like reactions. In this study, we used the largest pharmacovigilance database to describe ...
Clinical significance of detection of mononuclear phagocyte subsets in blood and bronchoalveolar lavage fluid (BALF) in pulmonary sarcoidosis
Clinical significance of detection of mononuclear phagocyte subsets in blood and bronchoalveolar lavage fluid (BALF) in pulmonary sarcoidosis
This study aimed to investigate the clinical significance of the detection of mononuclear phagocytes subsets in pulmonary sarcoidosis blood and bronchoalveolar lavage fluid (BALF)....

